Authors: Smith, IE O'Brien, MER Talbot, DC Nicolson, MC Mansi, JL Hickish, TF Norton, A Ashey, S

Citation: Ie. Smith et al., Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin, J CL ONCOL, 19(5), 2001, pp. 1336-1343

Authors: Bretherton-Watt, D Given-Wilson, R Mansi, JL Thomas, V Carter, N Colston, KW

Citation: D. Bretherton-watt et al., Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population, BR J CANC, 85(2), 2001, pp. 171-175

Authors: Senaratne, SG Pirianov, G Mansi, JL Arnett, TR Colston, KW

Citation: Sg. Senaratne et al., Bisphosphonates induce apoptosis in human breast cancer cell lines, BR J CANC, 82(8), 2000, pp. 1459-1468

Authors: Lofts, FJ Gogas, H Mansi, JL

Citation: Fj. Lofts et al., Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam), ANN ONCOL, 10(11), 1999, pp. 1389-1392

Authors: Mansi, JL Gogas, H Bliss, JM Gazet, JC Berger, U Coombes, RC

Citation: Jl. Mansi et al., Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study, LANCET, 354(9174), 1999, pp. 197-202

Authors: Primrose, JN Bleiberg, H Daniel, F Van Belle, S Mansi, JL Seymour, M Johnson, PW Neoptolemos, JP Baillet, M Barker, K Berrington, A Brown, PD Millar, AW Lynch, KP

Citation: Jn. Primrose et al., Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen, BR J CANC, 79(3-4), 1999, pp. 509-514